GFA
ANGO icon

Gallagher Fiduciary Advisors’s AngioDynamics ANGO Stock Holding History

Gallagher Fiduciary Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$521K Buy
45,832
+933
+2% +$10.1K 0.02% 153
2025
Q4 		$577K Buy
44,899
+4,067
+10% +$50.2K 0.02% 159
2025
Q3 		$456K Buy
+40,832
New +$394K 0.02% 180

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Gallagher Fiduciary Advisors's ANGO Position: Q1 2026 in Review

Gallagher Fiduciary Advisors increased its AngioDynamics (ANGO) stake by 2.1% in Q1 2026, buying an estimated $10.1K and bringing the position to 45,832 shares worth $521K. The position accounts for 0.02% of the portfolio, ranked #153.

Gallagher Fiduciary Advisors first reported a position in ANGO in Q3 2025 and has held it in 3 quarters since. The position peaked at $577K in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Gallagher Fiduciary Advisors held 45,832 shares of AngioDynamics worth $521K as of Q1 2026.
  • Gallagher Fiduciary Advisors bought 933 AngioDynamics shares in Q1 2026, an estimated $10.1K.
  • AngioDynamics made up 0.02% of Gallagher Fiduciary Advisors's portfolio in Q1 2026, its #153 holding.
  • Gallagher Fiduciary Advisors first reported a position in AngioDynamics in Q3 2025 and has held it in 3 quarters since.
  • Gallagher Fiduciary Advisors's AngioDynamics position peaked at $577K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Gallagher Fiduciary Advisors's 13F filing for Q1 2026, filed 15 May 2026.